BridgeBio Oncology Therapeutics (BBOT) Cash from Financing Activities (2024 - 2026)
BridgeBio Oncology Therapeutics (BBOT) reported Cash from Financing Activities of $37,000 for Q2 2026, down 99.8% from $18.96 million a year earlier and down 87.5% from the prior quarter.
Powered by 
Analysis
BridgeBio Oncology Therapeutics (BBOT) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BridgeBio Oncology Therapeutics' Cash from Financing Activities came in at $365.18 million, up 851.5% year-over-year; for FY2025, it was $383.4 million, up 85.9% from FY2024.
- By year, Cash from Financing Activities came in at $206.29 million in FY2024.
- Five-year quarterly Cash from Financing Activities spans a low of -$586,000 in Q4 2025 and a high of $365.44 million in Q3 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at $295,000 (Q1 2026), -$586,000 (Q4 2025) and $365.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | BridgeBio Oncology Therapeutics | 328.47 Mn | -1.04 Bn | - | 37,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37,000.00 |
| Mar 31, 2026 | 295,000.00 |
| Dec 31, 2025 | -586,000.00 |
| Sep 30, 2025 | 365.44 Mn |
| Jun 30, 2025 | 18.96 Mn |
| Mar 31, 2025 | -404,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 19.78 Mn |
| Mar 31, 2024 | 186.46 Mn |
API Access
BridgeBio Oncology Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BBOT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "BBOT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BBOT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();